索引于
  • 打开 J 门
  • Genamics 期刊搜索
  • 学术钥匙
  • 期刊目录
  • 研究圣经
  • 中国知网(CNKI)
  • 西马戈
  • 乌尔里希的期刊目录
  • 电子期刊图书馆
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-WorldCat
  • SWB 在线目录
  • 虚拟生物学图书馆 (vifabio)
  • 普布隆斯
  • 米亚尔
  • 科学索引服务 (SIS)
  • 欧洲酒吧
  • 谷歌学术
分享此页面
期刊传单
Flyer image

抽象的

Drug Delivery System for Controlled Cancer Therapy Using Physico-Chemically Stabilized Bioconjugated Gold Nanoparticles Synthesized from Marine Macroalgae, Padina Gymnospora

Manoj Singh, Manish Kumar, S Manikandan, N Chandrasekaran, Amitava Mukherjee and AK Kumaraguru

Gold nanoparticles (AuNPs) have always been considered as superior tools for biosystem applications owing to their characteristic optical properties in form of surface plasmon resonance and amperometric properties with very low or no immediate toxicity. Biosystem application based tools have been designed based on many studies with gold nanoparticles but the reduction of bulk material to nanosized particle in conjugation with biomolecules in a physicochemical environment is an area requiring deeper investigation. In the present study complementary high resolution imaging techniques on different length scale are applied to elucidate morphology of gold nanoparticles. The biomolecules involved in conjugation and reduction were further characterized. The impact of macroalgae broth concentration on formation of AuNPs (8-21 nm) were further studied to determine the functional and molecular mechanism of cell death on Liver cancer (HepG2) cell line and Lung cancer (A549) cell line. We report AuNPs-induced death response in human carcinoma liver cell line HepG2 in contrast to lung cancer cell line which remained little affected. The induction specificity
for death response in lung cells clarifies that AuNPs do not universally target all cell types. Altered DNA fragmentation and cell staining in different cancer cell suggests a potential for in vivo applications of gold nanomaterials and demands the need of the time for studies evaluating the interactions of nanomaterials with biomolecules and cellular components for controlled cancer therapy.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证